Woodline Partners’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.5M | Hold |
300,827
| – | – | 0.15% | 206 |
|
|
2025
Q1 | $19.1M | Sell |
300,827
-215,778
| -42% | -$13.7M | 0.12% | 234 |
|
|
2024
Q4 | $24M | Buy |
516,605
+8,660
| +2% | +$402K | 0.16% | 181 |
|
|
2024
Q3 | $14.6M | Buy |
507,945
+6,747
| +1% | +$194K | 0.12% | 230 |
|
|
2024
Q2 | $7.25M | Sell |
501,198
-338,569
| -40% | -$4.9M | 0.07% | 288 |
|
|
2024
Q1 | $13.5M | Buy |
839,767
+338,802
| +68% | +$5.45M | 0.12% | 223 |
|
|
2023
Q4 | $9.96M | Sell |
500,965
-85,757
| -15% | -$1.7M | 0.11% | 228 |
|
|
2023
Q3 | $9.56M | Buy |
586,722
+86,722
| +17% | +$1.41M | 0.11% | 230 |
|
|
2023
Q2 | $10.6M | Sell |
500,000
-1,244,264
| -71% | -$26.3M | 0.13% | 203 |
|
|
2023
Q1 | $35M | Buy |
1,744,264
+1,494,264
| +598% | +$30M | 0.48% | 52 |
|
|
2022
Q4 | $6.53M | Sell |
250,000
-125,033
| -33% | -$3.27M | 0.09% | 272 |
|
|
2022
Q3 | $3.83M | Sell |
375,033
-126,425
| -25% | -$1.29M | 0.05% | 344 |
|
|
2022
Q2 | $2.1M | Buy |
+501,458
| New | +$2.1M | 0.03% | 414 |
|